Search research articles
Contact Us
Filters
Showing results (801-810 of 881) with videos related to
Page
of 89
Sort By:
Nature Communications
|
March 17, 2022
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
Nanda Horeweg, Hagma H Workel, Dominik Loiero, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
Merve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Breast Cancer Research : BCR
|
January 8, 2016
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Stefanie de Groot, Ayoub Charehbili, Hanneke W M van Laarhoven, et al.
The British Journal of Surgery
|
April 18, 2018
Predictors of complications after direct-to-implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial
V L Negenborn, R E G Dikmans, M B Bouman, et al.
Breast Cancer Research and Treatment
|
January 6, 2015
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
S de Groot, L G M Janssen, A Charehbili, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 22, 2017
Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin
J Dierks, M P Gaspersz, A Belkouz, et al.
JCO Global Oncology
|
May 25, 2023
<i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
Anne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij, et al.
The European Respiratory Journal
|
July 19, 2014
Human leukocyte antigen class II variants and adult-onset asthma: does occupational allergen exposure play a role?
Lidwien A M Smit, David P Strachan, Roel Vermeulen, et al.
Annals of Hematology
|
April 11, 2013
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group
Noortje Thielen, Bronno van der Holt, Gregor E G Verhoef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2020
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, et al.
Page
of 89
Search research articles
Search
Showing results (801-810 of 881) with videos related to
Sort By:
Page
of 89
Nature Communications
|
March 17, 2022
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
Nanda Horeweg, Hagma H Workel, Dominik Loiero, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
Merve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Breast Cancer Research : BCR
|
January 8, 2016
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Stefanie de Groot, Ayoub Charehbili, Hanneke W M van Laarhoven, et al.
The British Journal of Surgery
|
April 18, 2018
Predictors of complications after direct-to-implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial
V L Negenborn, R E G Dikmans, M B Bouman, et al.
Breast Cancer Research and Treatment
|
January 6, 2015
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
S de Groot, L G M Janssen, A Charehbili, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 22, 2017
Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin
J Dierks, M P Gaspersz, A Belkouz, et al.
JCO Global Oncology
|
May 25, 2023
<i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
Anne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij, et al.
The European Respiratory Journal
|
July 19, 2014
Human leukocyte antigen class II variants and adult-onset asthma: does occupational allergen exposure play a role?
Lidwien A M Smit, David P Strachan, Roel Vermeulen, et al.
Annals of Hematology
|
April 11, 2013
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group
Noortje Thielen, Bronno van der Holt, Gregor E G Verhoef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2020
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, et al.
Page
of 89